Page 36 - A9Rc19d2z_zddyc4_fc0.tmp
P. 36

Radley, A., Pol, M. van der and Dillon, J.F. (2019) ‘Application   Reports
            of a discrete choice experiment approach to support
                                                           Dasgupta, R., Cameron, S., Aucott, L., MacLennan, G., Kilonzo,
            the design of a hepatitis C testing service in primary
                                                           M., Lam, T., Thomas, R., Norrie, J., McDonald, A., Anson, K.,
            care’, International Journal on Drug Policy, 65, 1-7.
                                                           N’Dow, J., Burgess, N., Clark, C., Keeley, F., MacLennan, S., Starr,
            Regier, D.A., Sicsic, J. and Watson, V. (2019) ‘Choice certainty   K. and McClinton, S. (2019) A multicentre randomised controlled
            and deliberative thinking in discrete choice experiments. A   trial of shockwave lithotripsy, as first treatment option, compared
            theoretical and empirical investigation’, Journal of Economic   with direct progression to ureteroscopic treatment, for ureteric
            Behavior & Organization, 164, 235-255.         stones (TISU trial). Final project report to National Institute
                                                           for Health Research (NIHR) Health Technology Assessment
            Ryan, M., Mentzakis, E., Matheson, C. and Bond, C. (2019)   Programme (Project Number 10/137/01).
            ‘Survey modes comparison in contingent valuation: internet
            panels and mail surveys’, Health Economics, [Epub ahead of   Hagen, S., Bugge, C., Dean, S.G., Elders, A., Hay-Smith,
            print].                                        J., Kilonzo, M., McClurg, D., Abdel-Fattah, M., Agur, W.I.,
                                                           Andreis, F., Booth, J., Dimitrova, M., Gillespie, N., Glazener,
            Tickle, M., Ricketts, D.J.N., Duncan, A., O’Malley, L., Donaldson,   C., Grant, A., Guerrero, K., Henderson, L., Kovandzic, M.,
            P.M., Clarkson, J.E., Black, M., Boyers, D., Donaldson, M., Floate,   McDonald, A., Norrie, J., Sergenson, N., Stratton, S., Taylor, A.
            R., Forrest, M.M., Fraser, A., Glenny, A.M., Goulao, B., McDonald,   and Williams, L.R. (2019) Basic versus biofeedback-mediated
            A., Ramsay, C.R., Ross, C., Walsh, T., Worthington, H.V., Young,   intensive pelvic floor muscle training for women with urinary
            L., Bonetti, D.L., Gouick, J., Mitchell, F.E., Macpherson, L.E., Lin,   incontinence: the OPAL RCT. Final project report to National
            Y.L., Pretty, I.A. and Birch, S. (2019) ‘Protocol for a Randomised   Institute for Health Research (NIHR) Health Technology
            controlled trial to Evaluate the effectiveness and cost benefit   Assessment Programme (Project Number 11/71/03).
            of prescribing high dose FLuoride toothpaste in preventing
            and treating dEntal Caries in high-risk older adulTs (REFLECT   Hernández, R., Robertson, C., Scott, N., Scotland, G., Booth,
            trial)’, BMC Oral Health, 19(1), 88.           C., Manson, P., Broadhurst, P. and Brazelli, M. (2019) TYRX
                                                           Absorbable Antibacterial Envelope for preventing infection
            Turner, S., Cotton, S.C., Emele, C.D., Thomas, R., Fielding, S.,   from cardiac implantable electronic devices, (NICE Technology
            Gaillard, E.A., de Jongste, J.C., Morgan, H., Neilson, A.R.,   Appraisal Guidance – GID-TA10370), Aberdeen Health
            Norrie, J., Pijnenburg, M., Price, D. and Thomas, M. (2019)   Technology Assessment Group.
            ‘Reducing Asthma Attacks in Children using Exhaled Nitric
            Oxide as a biomarker to inform treatment strategy: a   Imamura, M., Cooper, D., Hernández, R., Ormerod, T.,
            randomised trial (RAACENO)’, Trials, 20(1), 573.  Scotland, G. and Brazzelli, M. (2019) Risankizumab for treating
                                                           moderate-to-severe plaque psoriasis. A fast track appraisal,
            Watson, V., Dibben, C., Cox, M., Atherton, I., Sutton, M.   (NICE Technology Appraisal Guidance – TA596), Aberdeen
            and Ryan, M. (2019) ‘Testing the expert based weights used   Health Technology Assessment Group.
            in the UK’s Index of Multiple Deprivation (IMD) against three
            preference-based methods’, Social Indicators Research, 144(3),   Kopasker, D. and Montagna, C. (2019) Insecure employment
            1055-1074.                                     and mental health: one pathway in the productivity puzzle,
                                                           Small Project Report, Sheffield PIN – Productivity Insights
            Watson, V., Porteous, T., Bolt, T. and Ryan, M. (2019) ‘Mode   Network, University of Sheffield.
            and frame matter: assessing the impact of survey mode
            and sample frame in choice experiments’, Medical Decision   Robertson, C., Fielding, S., Walker, A., Kopasker, D.,
            Making, 39(7), 827-841.                        Vadiveloo, T., Manson, P., Price, G., Brazelli, M. and Scotland,
                                                           G. (2019) Lorlatinib for previously treated ALK-positive advanced
            Witham, M.D., Price, R.J.G., Band, M.M., Hannah, M.S., Fulton,   non-small-cell lung cancer, (NICE Technology Appraisal
            R.L., Clarke, C.L., Donnan, P.T., McNamee, P., Cvoro, V. and   Guidance – GID-TA10317), Aberdeen Health Technology
            Soiza, R.L. (2019) ‘Effect of vitamin K2 on postural sway in   Assessment Group.
            older people who fall: a randomized controlled trial’, Journal of
            the American Geriatrics Society, 67(10), 2102-2107.  Ryan, M., McKenzie, L., Mennie, L. and Miedzybrodzka, Z.
                                                           (2019) Valuing whole genome sequencing to improve diagnosis
                                                           of rare disorders: a health economic perspective. Report to
                                                           Scottish Genomics Partnership.



       36                                                                                   HERU ANNUAL REPORT 2019
   31   32   33   34   35   36   37   38   39   40   41